Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

14 years’ exclusivity for biologics is too long, says US govt
Pharma Times, UK
Thursday, June 11, 2009 - 9:19am
tags:
biologics, patents, FTC
Human Genome shares leap in pre-market trading
Marketwatch
Thursday, June 11, 2009 - 9:14am
tags:
Human Genome Sciences, Benlysta, lupus
Roche and Raptor unite to cross brain barrier
Hays Pharma, UK
Thursday, June 11, 2009 - 9:05am
tags:
Roche, Raptor Pharmaceuticals, partnerships
Access Pharma: Preparing to Advance Pipeline
Seeking Alpha
Thursday, June 11, 2009 - 9:02am
tags:
Access Pharmaceuticals, pipelines, cancer, biotech
Biotech Industry Investors More Cautious, Says Expert
Yahoo/Wall Street Transcript
Thursday, June 11, 2009 - 8:18am
tags:
biotech
NeurogesX: Positive Momentum
Seeking Alpha
Thursday, June 11, 2009 - 8:17am
tags:
NeurogesX, Qutenza
Eisai’s Aricept, Alzheimer’s Rivals Fail to Get Wider U.K. Use
Bloomberg
Thursday, June 11, 2009 - 8:16am
tags:
Eisai, Aricept, Alzheimer's disease, UK
Lilly balks at AG's $2B Zyprexa suit
Fierce Pharma
Wednesday, June 10, 2009 - 8:04pm
tags:
Eli Lilly, Zyprexa, lawsuits, West Virginia
Another Emory Psychiatrist Draws Fire for Payments From Glaxo
WSJ Online
Wednesday, June 10, 2009 - 8:03pm
tags:
GSK, physician payments
[video]Four Biotechs to Buy Now
Yahoo/CNBC
Wednesday, June 10, 2009 - 7:37pm
tags:
biotech
Pfizer executive reinforces prior company goal to boosting position in generic drug market
Yahoo/AP
Wednesday, June 10, 2009 - 6:42pm
tags:
Pfizer, generics
Drug stocks retract; Jazz sizzles ahead of data release
Marketwatch
Wednesday, June 10, 2009 - 5:25pm
tags:
Jazz Pharmaceuticals, drug stocks, fibromyalgia
Amarin autoimmune disease drug candidate meets study goals, confirming prior results
Yahoo/AP
Wednesday, June 10, 2009 - 5:24pm
tags:
Amarin, EN101, autoimmune disease
FDA panel backs 3 psychiatric drugs for kids
Yahoo/AP
Wednesday, June 10, 2009 - 5:12pm
tags:
FDA, Eli Lilly, Pfizer, AstraZeneca, Seroquel, Zyprexa
Endo Plays With Pain
Forbes
Wednesday, June 10, 2009 - 5:07pm
tags:
Endo, painkillers, pipelines
Novartis Near 50-day MA
Yahoo/Zacks.com
Wednesday, June 10, 2009 - 4:49pm
tags:
Novartis
Will Icahn’s Double Biotech Win Augur M&A Action?
WSJ Online
Wednesday, June 10, 2009 - 9:44am
tags:
Carl Icahn, biotech, Augur, M&A, Amylin, Biogen Idec
Vermont physician gift ban signed into law
Fierce Pharma
Wednesday, June 10, 2009 - 8:48am
tags:
Vermont, physician gifts
Dendreon: Charting the Course to Big Profits
Seeking Alpha
Wednesday, June 10, 2009 - 8:30am
tags:
Dendreon, Provenge, prostate cancer
NeuroSearch: Experimental Obesity Drug to Begin Phase 3 Trials
Seeking Alpha
Wednesday, June 10, 2009 - 8:26am
tags:
Neurosearch, obesity, Arena Pharmaceuticals, drug trials, Vivus, Orexigen, tesofensine

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.